To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZNF691TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
125 supporting clones for gene ZNF691 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI769861 pooled lung and spleen .a 1 to 749 1 to 748   tiling clone,   748/748
(100 %)
2 diff
(99.8 %id)
TI_57183278   .a 1 to 749 40 to 787       748/787
(95 %)
8 diff
(99.0 %id)
BM928293 brain .a 433 to 1481 22 to 1075       1054/1075
(98 %)
8 diff
(99.3 %id)
BQ052310 blood, natural killer cells, cell line .a 442 to 1481 1 to 1051       1051/1052
(99 %)
45 diff
(95.8 %id)
CR457146   .a 444 to 1294 1 to 851   tiling clone,   851/855
(99 %)
1 diff
(99.9 %id)
FN131700 breast carcinoma .a 616 to 669 54 to 1     Submitted on the opposite strand 54/55
(98 %)
0 diff
(100 %id)
TI_57149149   .a 677 to 1565 29 to 926       898/926
(96 %)
6 diff
(99.4 %id)
BI761586 pooled colon, kidney, stomach .a 681 to 1565 1 to 894       894/894
(100 %)
17 diff
(98.1 %id)
BG111587 Bone, osteosarcoma, cell line .a 707 to 1413 1 to 715       715/861
(83 %)
12 diff
(98.7 %id)
BM459350 lymph, lymphoma, cell line .a 855 to 1645 1 to 808       808/1072
(75 %)
24 diff
(97.8 %id)
AW026134 brain, glioblastoma (pooled) .a 898 to 1493 614 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 596/597
(99 %)
7 diff
(98.9 %id)
FN120555 breast carcinoma .a 902 to 987 1 to 86       86/87
(98 %)
1 diff
(98.9 %id)
BG742661 skin .a 974 to 1873 1 to 903       903/908
(99 %)
13 diff
(98.6 %id)
AA053768 colon, tumor .a 979 to 1349 1 to 373       373/374
(99 %)
3 diff
(99.2 %id)
BI522060 pooled pancreas and spleen .a 1037 to 1910 920 to 1       920/920
(100 %)
44 diff
(95.3 %id)
BG120962 adenocarcinoma, cell line, Liver .a 1039 to 1791 1 to 741       741/936
(79 %)
21 diff
(97.8 %id)
AI907684 breast .a 1154 to 1324 213 to 43       171/213
(80 %)
0 diff
(100 %id)
CU455442 epidermis .a 1161 to 1902 743 to 3     Submitted on the opposite strand 741/743
(99 %)
0 diff
(100 %id)
BU622004 Cell Line, Chondrosarcoma .a 1164 to 1958 813 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 795/795
(100 %)
2 diff
(99.8 %id)
BF948301 nervous_normal .a 1169 to 1357 189 to 1       189/189
(100 %)
1 diff
(99.5 %id)
CU453962 epidermis .a 1191 to 1889 714 to 16     Submitted on the opposite strand 699/714
(97 %)
0 diff
(100 %id)
BF948295 nervous_normal .a 1248 to 1357 110 to 1       110/110
(100 %)
0 diff
(100 %id)
AV700178.
matches multiple genes
hepatocellular carcinoma .a 1295 to 1962 664 to 1     also hits gene tyklorbu 664/666
(99 %)
14 diff
(97.9 %id)
T92392 lung .a 1298 to 1740 1 to 456       456/463
(98 %)
17 diff
(96.4 %id)
CX165865 human embryonic stem cells differentiated toan early endodermal cell type .a 1310 to 1958 1 to 649   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
CB047562 Kidney .a 1324 to 1424 1 to 101       101/101
(100 %)
4 diff
(96.1 %id)
BQ648736 hepatocellular carcinoma, cell line, Liver .a 1360 to 1961 1 to 604       604/1002
(60 %)
17 diff
(98.4 %id)
BQ646224 hepatocellular carcinoma, cell line, Liver .a 1360 to 1958 1 to 599   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 599/599
(100 %)
0 diff
(100 %id)
BF948292 nervous_normal .a 1375 to 1591 236 to 21       216/236
(91 %)
0 diff
(100 %id)
BF948299 nervous_normal .a 1375 to 1562 189 to 1       189/189
(100 %)
4 diff
(97.9 %id)
AA651685 Kidney, kidney tumor .a 1376 to 1687 1 to 312       312/312
(100 %)
0 diff
(100 %id)
AW026454 brain, glioblastoma (pooled) .a 1385 to 1869 576 to 92       485/576
(84 %)
0 diff
(100 %id)
AA845446 parathyroid gland, parathyroid tumor .a 1386 to 1909 524 to 1       524/524
(100 %)
0 diff
(100 %id)
AI700773 carcinoid, lung .a 1398 to 1959 562 to 1       562/562
(100 %)
1 diff
(99.9 %id)
BF439326 pooled .a 1412 to 1954 543 to 1       543/543
(100 %)
0 diff
(100 %id)
AI457794 carcinoid, lung .a 1413 to 1959 547 to 1       547/547
(100 %)
0 diff
(100 %id)
AW009361 colon .a 1433 to 1959 527 to 1       527/527
(100 %)
1 diff
(99.9 %id)
BF439262 pooled .a 1471 to 1954 484 to 1       484/484
(100 %)
4 diff
(99.2 %id)
AV763100 bone marrow .a 1474 to 1954 1 to 481   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 481/481
(100 %)
4 diff
(99.2 %id)
TI_153990694   .a 1479 to 1958 569 to 90   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 480/480
(100 %)
1 diff
(99.8 %id)
AW245618 lung, small cell carcinoma .a 1490 to 1958 479 to 11   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 469/469
(100 %)
8 diff
(98.3 %id)
BE218243 carcinoid, lung .a 1490 to 1961 472 to 1       472/472
(100 %)
0 diff
(100 %id)
AA053665 colon, tumor .a 1495 to 1959 467 to 1       467/467
(100 %)
3 diff
(99.4 %id)
AW206603   .a 1501 to 1958 475 to 18   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 458/458
(100 %)
0 diff
(100 %id)
AI343581 2 pooled tumors (clear cell type), Kidney .a 1514 to 1962 450 to 2       449/450
(99 %)
0 diff
(100 %id)
AA652460 normal prostate, Prostate .a 1516 to 1947 432 to 1       432/432
(100 %)
1 diff
(99.8 %id)
AW511732 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1549 to 1960 412 to 1       412/412
(100 %)
2 diff
(99.6 %id)
AW135883   .a 1550 to 1958 426 to 18   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 409/409
(100 %)
1 diff
(99.8 %id)
BQ308571 breast .a 1552 to 1910 26 to 383       358/386
(92 %)
7 diff
(98.2 %id)
AI373720 uterus .a 1564 to 1958 415 to 21   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 395/395
(100 %)
9 diff
(97.8 %id)
AI299130 carcinoid, lung .a 1566 to 1916 394 to 44       351/394
(89 %)
0 diff
(100 %id)
AI148160 brain, glioblastoma (pooled) .a 1599 to 1962 368 to 5   tiling clone,   364/368
(98 %)
0 diff
(100 %id)
AI249166 liver and spleen .a 1605 to 1958 354 to 1       354/354
(100 %)
0 diff
(100 %id)
AA932707 carcinoid, lung .a 1631 to 1957 328 to 1       328/328
(100 %)
1 diff
(99.7 %id)
BM726584 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1648 to 1958 1 to 311   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 311/311
(100 %)
0 diff
(100 %id)
EC470949 Prostate .a 1691 to 1799 1 to 109       109/109
(100 %)
4 diff
(96.4 %id)
AA581653 Kidney, kidney tumor .a 1698 to 1958 261 to 1       261/261
(100 %)
0 diff
(100 %id)
AA889096 pooled .a 1720 to 1962 249 to 7       243/249
(97 %)
0 diff
(100 %id)
AI565198 pooled .a 1756 to 1954 199 to 1       199/199
(100 %)
0 diff
(100 %id)
AI824533 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1762 to 1958 228 to 32   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 197/197
(100 %)
7 diff
(96.5 %id)
BI014132 lung_tumor .a 1796 to 1900 1 to 103       103/107
(96 %)
7 diff
(93.5 %id)
BE673617 carcinoid, lung .a 1800 to 1962 164 to 2       163/164
(99 %)
0 diff
(100 %id)
AW151320 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1809 to 1958 172 to 23   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 150/150
(100 %)
4 diff
(97.4 %id)
AI918174 anaplastic oligodendroglioma, brain .a 1815 to 1958 157 to 14   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 144/144
(100 %)
0 diff
(100 %id)
DC305044 cerebellum .b 1 to 583 1 to 585   tiling clone,   585/585
(100 %)
2 diff
(99.7 %id)
CN275535 embryonic stem cells, DMSO-treated H9 cellline .b 1 to 583 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
AK296201 thalamus .b 19 to 1470 1 to 1452 exact tiling clone,   1452/1452
(100 %)
0 diff
(100 %id)
DC340779 thalamus .b 19 to 584 1 to 566       566/566
(100 %)
0 diff
(100 %id)
AU117635 whole embryo, mainly head .b 306 to 1100 2 to 796   capped   795/799
(99 %)
11 diff
(98.7 %id)
AU144416 whole embryo, mainly head .b 1453 to 2016 571 to 1   tiling clone,   571/571
(100 %)
17 diff
(97.1 %id)
BC000157 Cervix, carcinoma .c 1 to 1652 1 to 1652 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1652/1652
(100 %)
0 diff
(100 %id)
CR618375 Neuroblastoma Cot 50-normalized .c 4 to 1622 1 to 1619 exact     1619/1619
(100 %)
0 diff
(100 %id)
AL529802 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c 4 to 833 1 to 824   fully sequenced,   824/824
(100 %)
4 diff
(99.6 %id)
AW674337 cervical carcinoma cell line, cervix .c 4 to 443 1 to 440       440/440
(100 %)
8 diff
(98.2 %id)
BI832779 pooled pancreas and spleen .c 5 to 739 14 to 759       746/760
(98 %)
45 diff
(94.1 %id)
TI_57162419   .c 5 to 739 41 to 786       746/787
(94 %)
43 diff
(94.6 %id)
AL563555 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .c 803 to 1622 822 to 1   fully sequenced,   822/822
(100 %)
16 diff
(98.1 %id)
AW674445 cervical carcinoma cell line, cervix .c 1232 to 1652 421 to 1       421/421
(100 %)
2 diff
(99.6 %id)
BX119573 whole brain .d 1 to 530 1 to 533       533/533
(100 %)
3 diff
(99.5 %id)
AF131739   .d 2 to 1574 1 to 1573 exact tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1573/1573
(100 %)
0 diff
(100 %id)
H08066 whole brain .d 2 to 393 1 to 393       393/394
(99 %)
7 diff
(98.3 %id)
NM_015911.2   .d 2 to 1574 1 to 1573 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1573/1573
(100 %)
0 diff
(100 %id)
R11682 whole brain .d 4 to 402 1 to 410       410/457
(89 %)
21 diff
(95.5 %id)
DN992236 brain, whole brain .d 10 to 718 1 to 710       710/710
(100 %)
5 diff
(99.3 %id)
AL709671 human skeletal muscle .d 16 to 587 10 to 581       572/572
(100 %)
0 diff
(100 %id)
TI_57183303   .d 16 to 703 29 to 717       689/717
(96 %)
10 diff
(98.7 %id)
BQ695224 adipose .d 18 to 663 1 to 654       654/654
(100 %)
25 diff
(96.2 %id)
BQ949046 sciatic nerve .d 18 to 886 1 to 871       871/894
(97 %)
4 diff
(99.6 %id)
BG169659 hypernephroma, cell line, Kidney .d 21 to 811 1 to 782       782/955
(81 %)
30 diff
(96.9 %id)
BI769884 pooled lung and spleen .d 21 to 703 1 to 684       684/684
(100 %)
1 diff
(99.9 %id)
BM928292 brain .d 28 to 1085 1 to 1066 K259E T273L H274T L275W G276A ...     1066/1069
(99 %)
39 diff
(96.4 %id)
DA681901 ovary .d 29 to 507 2 to 480   capped   479/479
(100 %)
0 diff
(100 %id)
BI522392 pooled pancreas and spleen .d 32 to 732 1 to 703       703/891
(78 %)
14 diff
(98.5 %id)
R17662 whole brain .d 1259 to 1578 327 to 5       323/327
(98 %)
0 diff
(100 %id)
H08067 whole brain .d 1339 to 1578 245 to 6       240/245
(97 %)
0 diff
(100 %id)
CN270482 embryonic stem cells, DMSO-treated H9 cellline .e 1 to 498 1 to 498   tiling clone,   498/498
(100 %)
0 diff
(100 %id)
BG330631 large cell carcinoma, lung .e 181 to 981 1 to 794 D146K E147M K148R P149S F150P ... tiling clone,   794/902
(88 %)
22 diff
(97.6 %id)
BG330221 large cell carcinoma, lung .e 182 to 529 2 to 343       342/344
(99 %)
11 diff
(96.9 %id)
DB469756 hippocampus .f 1 to 385 1 to 385   tiling clone,   385/453
(84 %)
9 diff
(98.1 %id)
TI_57200222   .f 46 to 724 62 to 740       679/740
(91 %)
8 diff
(99.0 %id)
BI819674 pooled brain, lung, testis .f 52 to 724 1 to 673   tiling clone,   673/673
(100 %)
2 diff
(99.8 %id)
AK095184 substantia nigra .g-u -8 to 2043 1 to 2053 A56G L57P A58G G60R R62T ... tiling clone, available from FLJ,   2053/2053
(100 %)
2 diff
(100.0 %id)
DA353091 substantia nigra .g-u 1 to 552 10 to 562 A56G L57P A58G G60R R62T ... capped   561/561
(100 %)
1 diff
(99.9 %id)
BF358679 lung_tumor .g-u 452 to 963 518 to 3       516/519
(99 %)
0 diff
(100 %id)
DB310412 substantia nigra .g-u 1511 to 2043 534 to 1       534/534
(100 %)
2 diff
(99.7 %id)
AA860260   .g-u 1562 to 2046 485 to 1       485/485
(100 %)
1 diff
(99.8 %id)
CB105122 Ascites, stomach .g-u 1690 to 2186 1 to 497   tiling clone,   497/497
(100 %)
0 diff
(100 %id)
DC378862 pericardium .h 1 to 572 1 to 572   tiling clone,   572/572
(100 %)
0 diff
(100 %id)
DC344583 cervix .h 42 to 604 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
BP307950 brain .h 45 to 627 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BF239961 bone marrow, from chronic myelogenous leukemia .h 50 to 641 1 to 601       601/825
(72 %)
33 diff
(96.0 %id)
TI_57150269   .h 51 to 825 31 to 805       775/805
(96 %)
12 diff
(98.6 %id)
DC396510 testis .h 51 to 598 1 to 550       550/550
(100 %)
3 diff
(99.5 %id)
BX490564   .h 53 to 660 1 to 609       609/609
(100 %)
4 diff
(99.4 %id)
BI763042 pooled colon, kidney, stomach .h 56 to 825 1 to 770       770/770
(100 %)
2 diff
(99.8 %id)
BM545525 brain, hippocampus .h 62 to 848 1 to 793   tiling clone, AAA   793/994
(79 %)
11 diff
(98.9 %id)
DC424191   .h 64 to 874 1 to 811   tiling clone,   811/811
(100 %)
11 diff
(98.7 %id)
BM801152 embryonal carcinoma, cell line, testis .h 84 to 734 1 to 656       656/986
(66 %)
10 diff
(99.0 %id)
N42467 melanocyte .h 86 to 489 34 to 447       414/467
(88 %)
21 diff
(95.6 %id)
BM757363 Ascites, stomach .h 188 to 756 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
BM741761 Ascites, stomach .h 188 to 821 1 to 634       634/634
(100 %)
0 diff
(100 %id)
AU099262   .h 245 to 544 1 to 300       300/300
(100 %)
1 diff
(99.7 %id)
BP254052 Kidney .h 245 to 829 1 to 585   tiling clone,   585/585
(100 %)
1 diff
(99.9 %id)
AU148820   .h 1359 to 1910 555 to 1   tiling clone,   555/556
(99 %)
8 diff
(98.6 %id)
BG748782 eye, normal pigmented retinal epithelium .i 1 to 537 1 to 545 C7G C9G F35V F36L L37F ... tiling clone,   545/545
(100 %)
22 diff
(96.0 %id)
BG748195 eye, normal pigmented retinal epithelium .i 2 to 586 1 to 578 C7V H8M C9L L10S V11G ... tiling clone,   578/578
(100 %)
8 diff
(98.7 %id)
DC358545 lung .j 1 to 577 8 to 585 exact tiling clone,   585/585
(100 %)
2 diff
(99.7 %id)
DB152105 thymus .k 1 to 588 2 to 589 exact tiling clone, capped   588/588
(100 %)
1 diff
(99.9 %id)
DA992545 synovial membrane tissue from rheumatioidarthritis .k 4 to 542 2 to 540 exact capped   539/539
(100 %)
0 diff
(100 %id)
DA193143 amygdala .k 11 to 501 2 to 492   capped   491/491
(100 %)
0 diff
(100 %id)
DB147078 thymus .k 20 to 559 2 to 541 exact capped   540/540
(100 %)
0 diff
(100 %id)
AW753368 colon .k 212 to 713 1 to 507 S13R T14Y F21L S40F S41I ... tiling clone,   507/507
(100 %)
13 diff
(97.5 %id)
CV319814 stomach .k 476 to 700 1 to 227   tiling clone,   227/230
(98 %)
8 diff
(96.6 %id)
AK000938 whole embryo, mainly head Gene ZNF691, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h, .i, .j, .k Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI